Concepedia

Therapeutic drug monitoring is predictive of loss of response after de-escalation of infliximab therapy in patients with inflammatory bowel disease in clinical remission

Aurélien Amiot, Anne Hulin, Mehdi Belhassan, Chantal André, Charlotte Gagnière, Yann Le Baleur, Jean‐Pierre Farcet, Jean‐Charles Delchier, Sophie Hüe

Clinics and Research in Hepatology and Gastroenterology · 2015 · 42 citations · 19 references

DOI

Concepts

References

19

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

Paul Rutgeerts, William J. Sandborn, Brian G. Feagan et al. · New England Journal of Medicine · 2005 · 3.9K citations · Full text

, , +14

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

Jack Satsangi · Gut · 2006 · 3.2K citations · Full text

, , +16

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch et al. · New England Journal of Medicine · 2010 · 3.1K citations · Full text

, , +14

A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY

Richard F. Harvey, J.M. Bradshaw · The Lancet · 1980 · 3K citations

, , +12

Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

Jean‐Frédéric Colombel, Paul Rutgeerts, Walter Reinisch et al. · Gastroenterology · 2011 · 919 citations · Full text

, , +16